Fmr LLC Aerovate Therapeutics, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Aerovate Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 153 shares of AVTE stock, worth $426. This represents 0.0% of its overall portfolio holdings.

Number of Shares

153

Previous 537,530 99.97%

Holding current value

$426

Previous $15.9 Million 100.0%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.41 - $30.75 $757,701 - $16.5 Million	-537,377 Reduced 99.97%	153 $0
Q1 2024 May 13, 2024	BUY	$17.68 - $29.57 $777 - $1,301	44 Added 0.01%	537,530 $15.9 Million
Q4 2023 Feb 13, 2024	BUY	$9.58 - $24.25 $76,084 - $192,593	7,942 Added 1.5%	537,486 $12.2 Million
Q3 2023 Nov 13, 2023	SELL	$12.9 - $18.88 $2.56 Million - $3.74 Million	-198,070 Reduced 27.22%	529,544 $7.19 Million
Q2 2023 Aug 11, 2023	BUY	$15.63 - $22.01 $2.45 Million - $3.45 Million	156,649 Added 27.44%	727,614 $12.5 Million
Q1 2023 May 11, 2023	BUY	$19.17 - $27.7 $2.18 Million - $3.15 Million	113,778 Added 24.89%	570,965 $11.5 Million
Q4 2022 Feb 13, 2023	SELL	$15.92 - $30.52 $1.08 Million - $2.07 Million	-67,873 Reduced 12.93%	457,187 $13.4 Million
Q3 2022 Nov 10, 2022	SELL	$14.77 - $25.79 $1.62 Million - $2.83 Million	-109,706 Reduced 17.28%	525,060 $8.71 Million
Q2 2022 Aug 12, 2022	SELL	$10.8 - $16.91 $914,846 - $1.43 Million	-84,708 Reduced 11.77%	634,766 $9.92 Million
Q1 2022 May 13, 2022	BUY	$8.25 - $18.33 $9,264 - $20,584	1,123 Added 0.16%	719,474 $13.2 Million
Q3 2021 Nov 15, 2021	SELL	$11.76 - $22.49 $2.09 Million - $3.99 Million	-177,466 Reduced 19.81%	718,351 $15.1 Million
Q2 2021 Aug 13, 2021	BUY	$22.83 - $22.83 $20.5 Million - $20.5 Million	895,817 New	895,817 $20.5 Million

Others Institutions Holding AVTE

# of Institutions

Shares Held

27.5M

Call Options Held

185K

Put Options Held

129K

View Full List

About Aerovate Therapeutics, Inc.

Ticker AVTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,448,100
Market Cap $68.2M
Description
Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...

More about AVTE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account